Oculoplastic surgery

  • 文章类型: Journal Article
    随着生物聚合物在医疗设备制造中的引入,材料科学与眼科医学之间的接口正在取得重大进展。这篇综述讨论了生物聚合物对眼科设备发展的影响,如人工晶状体,支架,和各种假肢。生物聚合物由于其生物相容性而成为卓越的替代品,机械坚固性,和生物降解性,在患者舒适度和环境因素方面,比传统材料有所进步。我们探索眼科设备中使用的生物聚合物的光谱,并评估其物理性质,与生物组织的相容性,和临床表现。眼整形和眼眶手术的具体应用,水凝胶在眼部治疗中的应用,和聚合物药物递送系统的一系列眼科条件进行了审查。我们还预测未来的方向并确定该领域的挑战,倡导材料科学和眼科实践之间的合作方法,以促进创新,以患者为中心的治疗。该合成旨在增强生物聚合物改善眼科装置技术和增强临床结果的潜力。
    The interface between material science and ophthalmic medicine is witnessing significant advances with the introduction of biopolymers in medical device fabrication. This review discusses the impact of biopolymers on the development of ophthalmic devices, such as intraocular lenses, stents, and various prosthetics. Biopolymers are emerging as superior alternatives due to their biocompatibility, mechanical robustness, and biodegradability, presenting an advance over traditional materials with respect to patient comfort and environmental considerations. We explore the spectrum of biopolymers used in ophthalmic devices and evaluate their physical properties, compatibility with biological tissues, and clinical performances. Specific applications in oculoplastic and orbital surgeries, hydrogel applications in ocular therapeutics, and polymeric drug delivery systems for a range of ophthalmic conditions were reviewed. We also anticipate future directions and identify challenges in the field, advocating for a collaborative approach between material science and ophthalmic practice to foster innovative, patient-focused treatments. This synthesis aims to reinforce the potential of biopolymers to improve ophthalmic device technology and enhance clinical outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    要确定皮肤镜检查是否,一种广泛用于皮肤病学的技术,用于改善皮肤病变的诊断,可以舒适地用于评估眶周,眼睑,和结膜病变。
    概念验证研究,其中开发了一种在眼睛附近进行皮肤镜检查的技术,准备了相关的教育材料,并创建了皮肤镜图像捕获的协议。
    技术人员使用开发的材料学习使用连接到标准手机摄像头的10倍皮肤镜拍摄高质量的照片。由眼整形外科医生和两名皮肤科医生评估图像的诊断实用性。
    拍摄了2021年7月至2023年4月从眼科诊所招募的115名患者,根据眼整形外科医生和两名皮肤科医生的评估,通过高质量的皮肤镜图像产生129个病变。
    技术人员报告说,训练后皮肤镜检查的置信度(以1-10量表测量)显着增加(教学前平均值=1.72,中位数=1,模式=1,IQR=1.25,平均值=7.69,中位数=7.75,模式=7和8,IQR=1.5。具有连续性校正的Wilcoxon秩和检验,W=0,p<0.001,配对t=13.95,p<0.0001)。在皮肤镜上结合具有4×4mm网状物的接触板,有助于拍摄眼部和眼周病变。
    可以教导眼科护理办公室的医疗支持人员使用皮肤镜捕获高质量的眶周图像,眼睑,和结膜病变。皮肤镜检查可阐明病变的诊断特征,从而为改善眼科决策提供了新途径。眼科医生可以将皮肤镜检查纳入远程医疗评估中,眼整形外科医生,或附属皮肤科医生对患者进行分类或提供建议,并在需要时进行手术计划。
    UNASSIGNED: To determine if dermoscopy, a technique widely utilized in dermatology for improved diagnosis of skin lesions, can be used comfortably for evaluating periorbital, eyelid, and conjunctival lesions.
    UNASSIGNED: Proof-of-concept study in which a technique for performing dermoscopy near the eye was developed, related educational material was prepared, and a protocol for dermoscopic image capture was created.
    UNASSIGNED: Technicians used the developed materials to learn to take high-quality pictures with a 10x dermoscope attached to a standard cell phone camera. The images were assessed for diagnostic utility by an oculoplastic surgeon and two dermatologists.
    UNASSIGNED: 115 patients recruited from ophthalmology clinics from July 2021 to April 2023 were photographed, yielding 129 lesions with high-quality dermoscopic images as assessed by an oculoplastic surgeon and two dermatologists.
    UNASSIGNED: Technicians reported a significant increase in confidence (measured on a 1-10 scale) with dermoscopy after training (pre-instruction mean = 1.72, median = 1, mode = 1, IQR = 1.25 vs mean = 7.69, median = 7.75, mode = 7 and 8, IQR = 1.5 post-instruction. Wilcoxon rank sum test with continuity correction, W = 0, p < 0.001, paired t = 13.95, p < 0.0001). Incorporating a contact plate with a 4 × 4mm reticule on the dermoscope aided in photographing ocular and periocular lesions.
    UNASSIGNED: Medical support staff in eye-care offices can be taught to use dermoscopes to capture high-quality images of periorbital, eyelid, and conjunctival lesions. Dermoscopy illuminates diagnostic features of lesions and thus offers a new avenue to improve decision-making in ophthalmology. Dermoscopy can be incorporated into telemedicine evaluations by ophthalmologists, oculoplastic surgeons, or affiliated dermatologists for triage of or rendering advice to patients and for planning of surgery if needed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在眼整形手术中,经常拉伸眼睑组织以修复肿瘤手术后的缺损。然而,关于伸展如何影响眼睑的研究很少。这项研究的目的是深入了解牵引力如何影响眼睑伸展以及组织灌注,使用基于激光的体内监测技术。
    对8例患者和总共9个眼睑进行了下睑五边形切除术。然后使用测力计将眼睑的内侧部分拉伸至2.3牛顿(N)的力,使用激光散斑对比成像连续测量眼睑伸展和血液灌注。
    当眼睑组织伸展时,组织灌注呈指数下降,最初的急剧下降,然后是更渐进的下降。灌注在大约2.0N的力下接近零。眼睑的长度随着力的增加而增加,直到1.5N,之后,长度只有很小的增加。
    眼睑组织似乎以非线性方式对牵引力做出反应,其中初始力导致最大的眼睑伸展和血液灌注减少。结果提供了有关直接闭合大眼睑缺损的较大力的影响的信息。考虑到灌注有多快接近零,眼睑重建手术的高成功率可能证明了眼周区域广泛的血管化。
    UNASSIGNED: In oculoplastic surgery the eyelid tissue is frequently stretched in order to repair defects after tumor surgery. However, there is a paucity of research regarding how stretching affects eyelids. The purpose of this study was to gain insight into how traction force affects eyelid stretch as well as tissue perfusion, using a laser-based in vivo monitoring technique.
    UNASSIGNED: Lower-lid pentagonal resections were performed in eight patients and a total of nine eyelids. The medial section of the eyelid was then stretched using a dynamometer up to a force of 2.3 Newtons (N), and eyelid stretching and blood perfusion were continuously measured using laser speckle contrast imaging.
    UNASSIGNED: Tissue perfusion decreased exponentially when eyelid tissue was stretched, with an initial sharp decline followed by a more gradual reduction. Perfusion approached zero at a force of approximately 2.0 N. The length of the eyelid increased with increasing force up to 1.5 N, after which there was only a very slight increase in length.
    UNASSIGNED: Eyelid tissue seems to respond to traction in a non-linear fashion, where the initial force results in the greatest eyelid stretching and reduction in blood perfusion. The results provide information on the effects of a large force for direct closure of large eyelid defects. Considering how quickly perfusion approaches zero, the high success rate of eyelid reconstruction surgery is likely a testament to the extensive vascularization of the periocular region.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:眼睑是皮肤肿瘤的常见部位,占所有皮肤肿瘤的5-10%。治疗主要是手术,旨在保留眼睑的解剖结构,它的功能,尤其是它的美学外观。
    目的:在一组450例肿瘤中,肿瘤相关眼睑手术的复发率和并发症发生率。
    结果:对一组450例手术肿瘤的分析显示,有13例(2.8%)手术复发,32例(7%)并发症。对于受累和未受累的睫状缘,观察到复发的统计学意义。在颞骨,23.1%的复发发生,而内侧can为7.7%。SGC的复发率最高。并发症包括:外翻,开裂,功能正常的毛瘢痕,撤回,辐射后损伤,移植物下出血和移植物排斥。
    结论:眼睑肿瘤的复发率低于并发症。手术技术的选择决定了并发症的发生频率和切除组织的组织学控制,以及复发的频率。
    The eyelids are a common site for skin tumours and account for 5-10% of all skin tumours. Treatment is mainly surgical and aims to preserve the anatomical structure of the eyelid, its function and not least its aesthetic appearance.
    Presentation of recurrence and complication rates of tumour-related eyelid surgery in a cohort of 450 tumours.
    Analysis of a cohort of 450 tumours operated on revealed 13 (2.8%) operations with recurrences and 32 (7%) with complications. The statistical significance of recurrences was observed for the involved and uninvolved ciliary margin. At the temporal canthus, 23.1% of recurrences occurred compared to 7.7% at the medial canthus. SGC has the highest recurrence rate. Complications include the following: ectropion, dehiscence, gross cicatrix with normal function, retraction, post-radiation damage, sub-graft haemorrhage and graft rejection.
    The recurrence rate of eyelid tumours is lower than that of complications. The choice of surgical technique determines the frequency of complications and histological control of the excised tissue, as well as the frequency of recurrences.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:评估眼整形手术是否可以在没有任何局部和全身抗生素的情况下进行,以“100%无抗生素”的方式。
    方法:我们在2017年11月至2022年12月之间进行了一项多中心回顾性研究。对接受眼眶手术的患者进行筛查。接受术前或术后全身抗生素的患者被排除在外。允许术中IV抗生素。患者分为两组:术后使用局部抗生素软膏治疗的患者(LATB组)和不使用局部抗生素软膏治疗的患者(LATB游离组)。主要结果是手术部位感染(SSI)的发生率。使用Fisher精确检验评估局部抗生素使用与SSI发生之间的关系。α风险设置为5%,并使用双尾测试。
    结果:在包括的947个程序中,LATB组中包括617个,LATB游离组中包括330个。853和80个程序分为Altemeier1级(清洁)和2级(清洁污染)手术,分别。总的来说,在没有任何全身或局部抗生素(100%无抗生素的方式)的情况下进行310例(32.73%)手术。在LATB和LATB游离组中,SSI分别发生在四个(4/617;0.65%)和五个(5/330;1.52%)程序中。组间无统计学差异(p=0.290)。通过排除预防性术中静脉注射抗生素进行的手术进行亚组分析,两组之间没有任何统计学差异(p=0.144)。所有SSI患者均接受全身抗生素治疗,结果良好。术后伤口裂开是与术后SSI相关的唯一危险因素(p=0.002)。
    结论:这项研究表明,在Altemeier1类和2类手术中,不使用全身和局部使用抗生素进行“100%无抗生素”眼整形手术是合理的。
    OBJECTIVE: To assess whether oculoplastic surgeries can be performed without any topical and systemic antibiotics, in a \"100% antibiotic free\" fashion.
    METHODS: We conducted a multicenter retrospective study between November 2017 and December 2022. Patients who underwent an oculoplastic procedure were screened. Patients who received preoperative or postoperative systemic antibiotics were excluded. Intraoperative IV antibiotics were allowed. Patients were divided into two groups: those who were treated with local antibiotics ointments (LATB group) and those who were treated without local antibiotics ointments (LATB free group) postoperatively. The primary outcome was the incidence of surgical site infections (SSI). The relationship between the use of local antibiotics and the occurrence of SSI was assessed using Fisher\'s exact test. The alpha risk was set to 5% and two-tailed tests were used.
    RESULTS: Among the 947 procedures included, 617 were included in the LATB group and 330 in the LATB free group. 853 and 80 procedures were classified Altemeier class 1 (clean) and class 2 (clean-contaminated) surgeries, respectively. Overall, 310 (32.73%) procedures were performed without any systemic nor topical antibiotics (100% antibiotic free fashion). SSI occured in four (4/617; 0.65%) and five (5/330; 1.52%) procedures in the LATB and LATB free group respectively, without any statistical difference between the groups (p = 0.290). A subgroup analysis was carried out by excluding the procedures performed under prophylactic intraoperative intravenous antibiotics and did not reveal any statistical difference between the two groups (p = 0.144). All SSI patients were treated with systemic antibiotics with favorable outcomes. Postoperative wound dehiscence was the only risk factor associated with postoperative SSI (p = 0.002).
    CONCLUSIONS: This study suggests that performing a \"100% antibiotic free\" oculoplastic surgery without systemic and topical antibiotics is reasonable in Altemeier class 1 and class 2 procedures.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在眼科创新的前沿,仿生3D打印和生物打印技术正在重新定义患者特定的治疗策略。这篇批判性评论系统地评估了它们的应用谱,跨越眼整形手术,视网膜组织工程,角膜移植,和有针对性的青光眼治疗。它突出了这些技术的复杂性,包括基本原则,先进材料,和促进眼组织结构复制的生物墨水。2014年至2023年的主要研究综合提供了对其演变和当前临床意义的严格分析。这篇综述在整体方法上是独一无二的,将科学基础与临床现实并列,从而描述了与传统模式相比的优势,识别翻译障碍。它阐明了持续存在的知识缺陷,并概述了未来的研究方向。它最终强调了多学科合作以加强这些生物技术的临床整合的必要性,最终导致朝着个性化眼科护理的范式转变。
    In the forefront of ophthalmic innovation, biomimetic 3D printing and bioprinting technologies are redefining patient-specific therapeutic strategies. This critical review systematically evaluates their application spectrum, spanning oculoplastic reconstruction, retinal tissue engineering, corneal transplantation, and targeted glaucoma treatments. It highlights the intricacies of these technologies, including the fundamental principles, advanced materials, and bioinks that facilitate the replication of ocular tissue architecture. The synthesis of primary studies from 2014 to 2023 provides a rigorous analysis of their evolution and current clinical implications. This review is unique in its holistic approach, juxtaposing the scientific underpinnings with clinical realities, thereby delineating the advantages over conventional modalities, and identifying translational barriers. It elucidates persistent knowledge deficits and outlines future research directions. It ultimately accentuates the imperative for multidisciplinary collaboration to enhance the clinical integration of these biotechnologies, culminating in a paradigm shift towards individualized ophthalmic care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    位于内侧的下眼睑缺损的手术重建可能具有挑战性。休斯程序,考虑到在这种情况下重建的标准,在美容效果方面往往达不到预期。一种将内侧转位与tel骨移植物和骨膜条相结合的替代方法已显示出希望。这里,我们的目的是证明与其他技术相比,保留的颞下眼睑内侧转位的美容优势。
    我们进行了一项回顾性研究,包括7名接受下述手术的有据可查的患者。该研究得到了大学伦理委员会的批准。
    所有患者随访1年。下眼睑缺损占其总长度的50-80%,位于眼睑的中部三分之一或中部到中部。术后并发症很少,所有患者都表现出良好的美容效果,功能,和随访时的解剖学结果。
    如果睫毛是侧向的,则可以很好地耐受睫毛。但是当缺陷在内侧时,内侧移位术可能是熟悉的休斯手术干预的良好替代方案。
    UNASSIGNED: Surgical reconstruction of medially located lower eyelid defects can be challenging. The Hughes procedure, considered the standard for reconstruction in such cases, often falls short in terms of cosmetic outcomes. An alternative approach that combines medial transposition with a tarsal graft and periosteal strip has shown promise. Here, we aim to demonstrate the cosmetic advantages of medial transposition of a preserved temporal lower eyelid over other techniques.
    UNASSIGNED: We conducted a retrospective study involving seven well-documented patients who underwent the procedure described below. The study was approved by the University\'s Ethics Committee.
    UNASSIGNED: All patients were followed up for one year. Lower eyelid defects spanned 50-80% of their total length, situated in the central third of the eyelid or the central to medial portion. Postoperative complications were minimal, with all patients exhibiting good cosmetic, functional, and anatomical outcomes at follow-up.
    UNASSIGNED: The absence of eyelashes is well tolerated if it is lateral, but when the defect is medial, medial transposition could be a good alternative to the familiar Hughes surgical intervention.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:调查大流行期间在我们机构进行眼整形手术远程医疗访问的模式。方法:回顾性分析2020年3月1日至2021年3月1日期间在梅奥诊所罗切斯特的眼整形外科服务进行虚拟咨询的所有患者。结果:共148例患者。平均年龄为65岁(95%置信区间[CI]:62-68)。到医疗中心的平均行驶距离为468公里(95%CI:352-586),15名(10%)患者来自没有执业的美国眼科整形和重建外科学会(ASOPRS)成员的州。在205次虚拟访问中,35(17%)是新的,45人(22%)返回,术后125例(61%)。手术转化率为60%。虚拟访问类型之间的比较(新与返回vs.术后)显示,眼睑错位的诊断在术后就诊中最常见(p=<0.001),皮肤恶性肿瘤在新就诊中最常见(p=0.009),和眼眶肿瘤(p=0.018)和甲状腺眼病(p=<0.001)在回访中最常见。大多数虚拟接触都附加了支持媒体,包括127次(62%)访问中的外部照片和18次(9%)访问中的其他成像或测试。平均虚拟访问持续18分钟(95%CI:14-22),其中9次(4%)访问中出现技术困难。在三起(1%)病例中,意外转换为亲自访问。结论:在COVID-19大流行期间,多种眼整形手术条件得到了实际控制。初始虚拟就诊与随访护理的利用因诊断而异。虚拟访问可能会改善来自服务不足地区的患者获得眼部整形亚专科护理的机会。
    Purpose: To investigate patterns in oculoplastic surgery telemedicine visits at our institution during the pandemic period. Methods: Retrospective chart review of all patients who had a virtual consultation with the oculoplastic surgery service at Mayo Clinic Rochester between March 1, 2020, and March 1, 2021. Results: There were a total of 148 patients. Mean age was 65 years (95% confidence interval [CI]: 62-68). The mean driving distance to the medical center was 468 kilometers (95% CI: 352-586) and 15 (10%) patients came from states with no practicing American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) members. Out of the 205 virtual visits, 35 (17%) were new, 45 (22%) were return, and 125 (61%) were postoperative. Conversion rate to surgery was 60%. A comparison between type of virtual visits (new vs. return vs. postoperative) revealed that a diagnosis of eyelid malposition was most frequent in postoperative visits (p = < 0.001), skin malignancy was most frequent in new visits (p = 0.009), and orbital tumors (p = 0.018) and thyroid eye disease (p = < 0.001) were most frequent in return visits. Most virtual encounters had supportive media attached including external photographs in 127 (62%) visits and other imaging or testing in 18 (9%) visits. The average virtual visit lasted 18 min (95% CI: 14-22) with technical difficulties noted in 9 (4%) visits. Unanticipated conversion to in-person visits was noted in three (1%) cases. Conclusions: A wide range of oculoplastic surgery conditions was managed virtually during the COVID-19 pandemic. Utilization of initial virtual visit versus follow-up care varied by diagnosis. Virtual visits may improve access to oculoplastic subspecialty care for patients from underserved areas.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    生物聚合物在眼睑和泪道系统后层重建中的应用标志着生物材料科学与临床进步的重要融合。这篇综述吸收了2015年至2023年的研究,以详细研究生物聚合物在重建眼睑后层和泪道系统中的作用。它涵盖了眼睑结构的解剖学和病理生理学,重建的挑战,以及手术干预的细微差别。本文进展到评估当前的黄金标准,替代选项,以及这些复杂程序中使用的生物聚合物的理想特性。它强调了该领域的进步,从脱细胞移植物和无细胞基质到创新的天然和合成聚合物,并探讨了它们在泪腺组织工程中的应用,包括3D生物打印技术的承诺。这篇综述强调了材料科学家和临床医生之间的多学科合作在提高手术结果和患者生活质量方面的重要性。强调这种合作对于将台式研究转化为床边应用至关重要。这种协作努力对于恢复患有眼睑疾病的患者的美学和功能至关重要,最终旨在弥合创新材料与其临床翻译之间的差距。
    The application of biopolymers in the reconstruction of the posterior lamella of the eyelid and the lacrimal system marks a significant fusion of biomaterial science with clinical advancements. This review assimilates research spanning 2015 to 2023 to provide a detailed examination of the role of biopolymers in reconstructing the posterior lamella of the eyelid and the lacrimal system. It covers the anatomy and pathophysiology of eyelid structures, the challenges of reconstruction, and the nuances of surgical intervention. This article progresses to evaluate the current gold standards, alternative options, and the desirable properties of biopolymers used in these intricate procedures. It underscores the advancements in the field, from decellularized grafts and acellular matrices to innovative natural and synthetic polymers, and explores their applications in lacrimal gland tissue engineering, including the promise of 3D bioprinting technologies. This review highlights the importance of multidisciplinary collaboration between material scientists and clinicians in enhancing surgical outcomes and patient quality of life, emphasizing that such cooperation is pivotal for translating benchtop research into bedside applications. This collaborative effort is vital for restoring aesthetics and functionality for patients afflicted with disfiguring eyelid diseases, ultimately aiming to bridge the gap between innovative materials and their clinical translation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的该研究的目的是评估使用膨体聚四氟乙烯(ePTFE)吊带进行先天性上睑下垂修复的额肌悬吊术后的短期和长期功能结果。方法回顾性分析,我们对2008年至2020年期间使用ePTFE吊带行额骨悬吊术的儿科患者进行了观察性病例回顾.通过盖子高度评估功能成功,盖子对称,和父母对美容结果的满意度。评估手术后的临床过程和长期功能结果。结果21例符合纳入标准并进行评估。随访时间13个月至11年,平均6年。一次手术后的功能成功率在术后早期和晚期为62%。21例中有6例(29%)由于矫正不足而在术后早期需要进行修正手术。3例(14%)并发感染和/或肉芽肿形成。如果在术后早期看到成功,则从长远来看没有上睑下垂复发的病例。结论ePTFE吊索仍然是额肌吊索修复严重先天性上睑下垂的理想选择。证明了长期的功能成功,具有令人满意的盖子对称性和可接受的美容结果。这对于三岁以下的患者来说是重要的考虑因素,不推荐使用自生材料。需要进行早期修正手术以进行矫正不足并不少见。目前的作者还证明了感染和/或肉芽肿形成的低但相当大的风险。
    Purpose The purpose of the study is to assess short- and long-term functional outcomes after frontalis suspension using expanded polytetrafluoroethylene (ePTFE) sling for congenital ptosis repair. Methods A retrospective, observational case review was conducted on pediatric patients who underwent frontalis suspension using ePTFE sling from 2008 to 2020. Functional success was assessed by lid height, lid symmetry, and parental satisfaction with the cosmetic outcome. Clinical course and long-term functional outcomes after surgery were assessed. Results Twenty-one cases met the inclusion criteria and were assessed. The follow-up time ranged from 13 months to 11 years (mean: six years). Functional success after one surgery was 62% at early and late postoperative periods. Six of 21 cases (29%) required revisional surgery in the early postoperative period due to undercorrection. Three cases (14%) were complicated by infection and/or granuloma formation. There were no cases of ptosis recurrence in the long term if success was seen in the early postoperative period. Conclusion ePTFE slings remain an excellent option for severe congenital ptosis repair with frontalis sling, demonstrating long-term functional success, with satisfactory lid symmetry and acceptable cosmetic outcome. This is of important consideration in patients younger than three years of age, where autogenous materials may not be recommended. The need for early revisional surgery for undercorrection is not uncommon. The current authors also demonstrate a low but considerable risk for infection and/or granuloma formation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号